Betting On Cancer Treatment? Keep An Eye On This Company

By: via Benzinga
NeoStem Inc (NASDAQ: NBS) recently received a grant of $17.7 million to fund the company's effort in research of cell therapy ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.